A clinical chemistry analyzer is use to analyze blood serum, plasma, urine and other body fluids with the help of various measurement technologies such as photometric and colorimetric testing, ion-selective potentiometry, and latex agglutination. The chemical analyzers can be employed in small point-of-care clinics and high-throughput clinical labs to determine concentration of metabolites, proteins, sugars, and electrolytes and others. In this device, samples are first inserted in a slot or tray, programmed through a keypad, and results are displayed on a screen. The analyzers are available as bench top models, compact bedside models, and high-throughput floor-based units. Clinical analyzers are used to monitor diseases such as diabetes, testing for metabolic functions or cardiac markers, and drugs-of-abuse testing. Technological advancements in clinical chemistry analyzers enable users to obtain accurate results in less time.
The clinical chemical analyzers market in North America is expected to register a significant growth due to rising healthcare expenditure, increasing incidences of contagious diseases, such as tuberculosis, malaria, and growing records of criminal activities. The market is also poised to grow concurrently with the development of new assays, advent of customized analyzers and development of software, which would increase testing speed and degree of automation. However, high cost of device and shortage of skilled professionals are the restraining factors of the market.
North America clinical chemistry analyzer market is segmented into of type, technology, end user, and geography. On the basis of type, the market is classified into semi-automated and fully-automated analyzers. Further, the fully automated analyzer market is classified into entry level, medium throughput, large high throughput, and ultra large high throughput based on tests per hour. Based on technology, the market is categorized into wet and dry chemistry. End user market is classified into academic research institutes, diagnostic laboratories, hospitals, and other end users. The market is divided geographically into U.S., Canada, and Mexico.
The major manufacturers of clinical chemistry analyzers are Abbott Diagnostics, Roche Diagnostics, Beckman Coulter, Siemens AG, Thermo Fisher Scientific, Ortho-Clinical Diagnostics, Randox Laboratories Ltd., ElitechGroup, Horiba, and Mindray. Some of the key strategies, such as partnerships, mergers, joint ventures, and new product launches have been implemented by them to strengthen their position in the industry.
KEY BENEFITS FOR STAKEHOLDERS:
KEY MARKET SEGMENTS:
SIMILAR MARKET STUDIES
China Potential Non-Invasive Prenatal Testing (NIPT) market is likely to reach more than US$ 1.7 Billion by 2024. Long-term Growth Projection and Development: • It is predicted that China Actual NIPT test volume will increase to 1.6 Million by 2024 • More than 3,00,000 NIFTY tests done in 2016 • Berry Genomics completes US$ ...
September 2017 | $800 | View Details >>
Chenguang Biotech Group Co Ltd (300138) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses ...
September 2017 | $125 | View Details >>
Plant Extracts is a kind of matter which extracts from the plant or the parts of plant by the suitable solvent or methods, it can used to the pharmaceutical industry, food industry, healthy industry, beauty industry and other industries. Scope of the Report: This report focuses on the Plant Extracts in Europe ...
September 2017 | $4480 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research